基化干扰素α-2b与标准干扰素α-2b,再加上利巴维林,用于艾滋病毒感染患者的慢性型肝炎:随机对照试验
相关实验视频
Updated: May 13, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 10, 2014
Fabrice Carrat1, Firouzé Bani-Sadr, Stanislas Pol
1Groupe Hospitalier Universitaire Est, Université Paris 6, INSERM U444, Paris, France.
JAMA
|December 16, 2004
概括
与标准干扰素α-2b相比,干扰素α-2b加上瑞巴维林在与人类免疫缺陷病毒 (HIV) 同感染的患者中治疗慢性肝炎C病毒 (HCV) 感染的疗效更大. 这种组合疗法为HIV-HCV共感染个体提供了改善的持续病毒学反应率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 患有人类免疫缺陷病毒 (HIV) 的患者慢性肝炎C病毒 (HCV) 感染是一个重大的临床挑战.
- 现有的关于该群体治疗有效性和安全性的数据通常来自于不受控制的研究.
研究的目的:
- 为了比较 peginterferon alfa-2b 加上 ribavirin 与标准干扰素 alfa-2b 加上 ribavirin 的安全性和疗效,在 HIV 和 HCV 同感染的患者中.
- 评估两个治疗方案的持续病毒学反应率和耐受性.
主要方法:
- 一个多中心的,随机的,开放的标签试验,涉及412名HIV-HCV共感染患者,可检测HCV-RNA和特定的免疫学标准.
- 患者接受了干扰素α-2b或标准干扰素α-2b,两者与利巴维林结合,持续48周.
- 持续的病毒学反应被定义为72周未检测到的血清HCV-RNA.
主要成果:
- 与标准干扰素α-2b加利巴维林 (20%,P = .047) 相比,干扰素α-2b加利巴维林的持续病毒学反应率 (27%) 达到较高的水平.
- 对于HCV基因型1或4的患者 (17%与6%,P = .006) 的益处是显著的,但对于基因型2,3或5 (44%与43%,P = .88) 的患者没有.
- 治疗失败的预测因素包括HCV-RNA下降<2 log10和可检测的HCV-RNA在12周;病毒学反应者显示组织学活性下降和纤维化稳定.
结论:
- 干扰素α-2b与利巴维林结合治疗HIV共感染患者的HCV感染,比标准干扰素α-2b更有效.
- 该研究强调了HCV基因型在治疗反应中的重要性,并确定了预测治疗失败的早期病毒学标志物.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

